Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
survivin-peptide double loaded dendritic cells (1 trial)
Carcinoma, Ovarian Epithelial (Phase 1)
Trials (1 total)
Trial APIs (1 total)